ArticleCell biochemistry and biophysics2026
miR-155-SOCS1-Telomere Length Axis: A Tripartite and Multifaceted Approach To Understanding Rheumatoid Arthritis Pathophysiology.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA), a chronic autoimmune condition that causes joint inflammation due to altered genetic expression in synovial tissue, affects 1% of the world’s population. miRNAs play a crucial role in regulating telomere length and gene expression. Elevated miR-155 expression significantly promotes RA progression by inhibiting SOCS1, an anti-inflammatory gene, and thereby enhancing the production of IL-1 and TNF-α. miR-155 has also been found to target the shelterin complex, resulting in shorter telomeres. The current study was designed to understand the molecular mechanism underlying the miR-155-SOCS1-TL axis in RA. We observed shorter telomere lengths, reduced SOCS1, and elevated miR-155 expression in RA patients relative to the control. The results of the Pearson correlation coefficient confirmed the negative correlation of miR-155 with the SOCS1 gene and telomere length. The results of univariate and multivariate logistic regression analyses did not indicate any association between genetic parameters and age or sex. The promoter analysis of the SOCS1 gene revealed the presence of G-rich sequences and a CCAATT box. Docking of miR-155 with SOCS1 promoter 1 (− 501 to + 10 bp) and 2 (− 1000 to − 500 bp) revealed binding scores of − 993.30 and − 851.57 kcal/mol. Similarly, the molecular interaction analysis of miR-155 with TRF1 yielded a docking score of − 324.26 kcal/mol and was further confirmed by molecular simulations and MM-PBSA free-energy calculations. Together, the study findings suggested that the miR-155-SOCS1-TL axis could be a promising therapeutic target for RA management.
Indexed as
Identifiers
41549164What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.